159 related articles for article (PubMed ID: 7556150)
1. Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.
Lind P; Larsson K; Spira J; Sydow-Bäckman M; Almstedt A; Gray E; Sandberg H
Eur J Biochem; 1995 Aug; 232(1):19-27. PubMed ID: 7556150
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.
Sandberg H; Almstedt A; Brandt J; Gray E; Holmquist L; Oswaldsson U; Sebring S; Mikaelsson M
Thromb Haemost; 2001 Jan; 85(1):93-100. PubMed ID: 11204595
[TBL] [Abstract][Full Text] [Related]
3. Amino acid residues 721-729 are required for full factor VIII activity.
Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.
Bihoreau N; Paolantonacci P; Bardelle C; Fontaine-Aupart MP; Krishnan S; Yon J; Romet-Lemonne JL
Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):23-31. PubMed ID: 1906711
[TBL] [Abstract][Full Text] [Related]
5. Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity.
Mertens K; Donath MJ; van Leen RW; de Keyzer-Nellen MJ; Verbeet MP; Klaasse Bos JM; Leyte A; van Mourik JA
Br J Haematol; 1993 Sep; 85(1):133-42. PubMed ID: 8251380
[TBL] [Abstract][Full Text] [Related]
6. Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII delta II.
Krishnan S; Kolbe HV; Lepage P; Faure T; Sauerwald R; de la Salle H; Muller C; Bihoreau N; Paolantonacci P; Roitsch C
Eur J Biochem; 1991 Feb; 195(3):637-44. PubMed ID: 1900236
[TBL] [Abstract][Full Text] [Related]
7. Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system.
Orlova NA; Kovnir SV; Gabibov AG; Vorobiev II
BMC Biotechnol; 2017 Mar; 17(1):33. PubMed ID: 28340620
[TBL] [Abstract][Full Text] [Related]
8. Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r)).
David D; Saenko EL; Santos IM; Johnson DJ; Tuddenham EG; McVey JH; Kemball-Cook G
Br J Haematol; 2001 Jun; 113(3):604-15. PubMed ID: 11380445
[TBL] [Abstract][Full Text] [Related]
9. Efficient production of recombinant human factor VIII by co-expression of the heavy and light chains.
Yonemura H; Sugawara K; Nakashima K; Nakahara Y; Hamamoto T; Mimaki I; Yokomizo K; Tajima Y; Masuda K; Imaizumi A
Protein Eng; 1993 Aug; 6(6):669-74. PubMed ID: 8234237
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII.
Schmidbauer S; Witzel R; Robbel L; Sebastian P; Grammel N; Metzner HJ; Schulte S
Thromb Res; 2015 Aug; 136(2):388-95. PubMed ID: 26037285
[TBL] [Abstract][Full Text] [Related]
11. A new recombinant procoagulant protein derived from the cDNA encoding human factor VIII.
Meulien P; Faure T; Mischler F; Harrer H; Ulrich P; Bouderbala B; Dott K; Sainte Marie M; Mazurier C; Wiesel ML
Protein Eng; 1988 Oct; 2(4):301-6. PubMed ID: 3150544
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule.
Eaton DL; Wood WI; Eaton D; Hass PE; Hollingshead P; Wion K; Mather J; Lawn RM; Vehar GA; Gorman C
Biochemistry; 1986 Dec; 25(26):8343-7. PubMed ID: 3030393
[TBL] [Abstract][Full Text] [Related]
13. Enhanced production of recombinant B-domain deleted factor VIII from Chinese hamster ovary cells by propionic and butyric acids.
Chun BH; Park SY; Chung N; Bang WG
Biotechnol Lett; 2003 Feb; 25(4):315-9. PubMed ID: 12882544
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins.
Demasi MA; de S Molina E; Bowman-Colin C; Lojudice FH; Muras A; Sogayar MC
Mol Biotechnol; 2016 Jun; 58(6):404-14. PubMed ID: 27126696
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a recombinant antihaemophilia-A factor (factor VIII-delta II) by matrix-assisted laser desorption/ionization mass spectrometry.
Bihoreau N; Veillon JF; Ramon C; Scohyers JM; Schmitter JM
Rapid Commun Mass Spectrom; 1995; 9(15):1584-8. PubMed ID: 8652881
[TBL] [Abstract][Full Text] [Related]
16. A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity.
Toole JJ; Pittman DD; Orr EC; Murtha P; Wasley LC; Kaufman RJ
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5939-42. PubMed ID: 3016730
[TBL] [Abstract][Full Text] [Related]
17. Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells.
Kaufman RJ; Wasley LC; Davies MV; Wise RJ; Israel DI; Dorner AJ
Mol Cell Biol; 1989 Mar; 9(3):1233-42. PubMed ID: 2498645
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence.
Ehlers MR; Schwager SL; Scholle RR; Manji GA; Brandt WF; Riordan JF
Biochemistry; 1996 Jul; 35(29):9549-59. PubMed ID: 8755736
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII.
Pittman DD; Wang JH; Kaufman RJ
Biochemistry; 1992 Apr; 31(13):3315-25. PubMed ID: 1554716
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A.
Nord K; Nord O; Uhlén M; Kelley B; Ljungqvist C; Nygren PA
Eur J Biochem; 2001 Aug; 268(15):4269-77. PubMed ID: 11488921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
